The current study reveals a novel therapeutic mechanism by which BM-MSC-derived migrasomes alleviate poststroke immunosuppression through targeted delivery of the Pin1 protein to TEC, thereby reversing stroke-induced thymic atrophy and restoring peripheral immune homeostasis. The gene discussed is PIN1; the disease is thymus atrophy.